home / stock / bgne / bgne short
Short Information | BeiGene Ltd. (NASDAQ:BGNE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 838,459 |
Total Actual Volume | 5,545,886 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 41,923 |
Average Short Percentage | 15.39% |
Is there a BGNE Short Squeeze or Breakout about to happen?
See the BGNE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
09-17-2024 | $199.05 | $197.51 | $200.69 | $196.615 | 103,859 | 19,389 | 18.67% |
09-16-2024 | $196.43 | $196.45 | $197.53 | $194.075 | 204,525 | 32,055 | 15.67% |
09-13-2024 | $200 | $198.49 | $200.61 | $195.71 | 212,446 | 30,955 | 14.57% |
09-12-2024 | $199 | $196.27 | $200.75 | $194.11 | 483,661 | 107,029 | 22.13% |
09-11-2024 | $206.62 | $211.15 | $215 | $205.6 | 602,657 | 75,854 | 12.59% |
09-10-2024 | $191.76 | $197.7 | $198.525 | $191.73 | 182,742 | 35,471 | 19.41% |
09-09-2024 | $189.67 | $193.31 | $193.47 | $189.21 | 144,720 | 20,256 | 14% |
09-06-2024 | $192.81 | $191.32 | $193.035 | $188.515 | 136,979 | 26,090 | 19.05% |
09-05-2024 | $190.21 | $191.58 | $194.57 | $190.21 | 178,182 | 27,974 | 15.7% |
09-04-2024 | $187.09 | $188.65 | $191.2 | $186.03 | 516,226 | 46,152 | 8.94% |
09-03-2024 | $190.03 | $188.26 | $192.98 | $187.68 | 364,414 | 33,891 | 9.3% |
08-30-2024 | $196.02 | $191.78 | $196.37 | $190.74 | 293,438 | 39,987 | 13.63% |
08-29-2024 | $197.85 | $198.5 | $199.645 | $196.75 | 135,710 | 13,441 | 9.9% |
08-28-2024 | $200.91 | $198.16 | $201.56 | $196 | 163,599 | 20,820 | 12.73% |
08-27-2024 | $200.02 | $202.17 | $202.59 | $199.745 | 313,595 | 42,513 | 13.56% |
08-26-2024 | $199.64 | $199.22 | $201.28 | $197.68 | 429,048 | 72,731 | 16.95% |
08-23-2024 | $194.39 | $193.82 | $196.32 | $191.11 | 207,855 | 36,461 | 17.54% |
08-22-2024 | $199 | $195.63 | $199 | $195.36 | 254,755 | 39,513 | 15.51% |
08-21-2024 | $196 | $197.98 | $199 | $195.63 | 336,398 | 69,163 | 20.56% |
08-20-2024 | $194.19 | $194.21 | $195.98 | $192.845 | 281,077 | 48,714 | 17.33% |
News, Short Squeeze, Breakout and More Instantly...
2024-09-18 04:15:06 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for BGNE on September 18, 2024 02:12AM ET. BGNE was trading at $197.51 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are :...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Israeli Ministry of Health (IL MOH) has approved TEVIMBRA® (tislelizumab) as monotherapy for the treatment of adult patients with unresectable or metastatic oesophageal squamous cell c...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 8.1% to $116.91 on volume of 431,533,576 shares CN Energy Group Inc. (CNEY) rose 366.1% to $1.39 on volume of 337,403,253 shares FTC Solar Inc. (FTCI) rose 104.0% to $0.4592 on volume of 280,973,331 shares...